Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 15 studies | 24% ± 6% | |
oligodendrocyte | 13 studies | 42% ± 18% | |
microglial cell | 11 studies | 42% ± 16% | |
oligodendrocyte precursor cell | 10 studies | 47% ± 19% | |
GABAergic neuron | 9 studies | 44% ± 19% | |
macrophage | 9 studies | 29% ± 14% | |
smooth muscle cell | 8 studies | 26% ± 8% | |
glutamatergic neuron | 8 studies | 31% ± 14% | |
endothelial cell of lymphatic vessel | 8 studies | 46% ± 15% | |
astrocyte | 7 studies | 37% ± 18% | |
fibroblast | 6 studies | 29% ± 9% | |
type I pneumocyte | 5 studies | 44% ± 9% | |
type II pneumocyte | 5 studies | 41% ± 7% | |
cholangiocyte | 4 studies | 57% ± 20% | |
hepatocyte | 4 studies | 64% ± 31% | |
mesothelial cell | 4 studies | 39% ± 9% | |
epithelial cell | 4 studies | 40% ± 22% | |
retinal cone cell | 4 studies | 30% ± 12% | |
myeloid cell | 4 studies | 31% ± 15% | |
club cell | 4 studies | 42% ± 16% | |
interneuron | 4 studies | 66% ± 25% | |
GABAergic interneuron | 3 studies | 50% ± 3% | |
ependymal cell | 3 studies | 41% ± 3% | |
ciliated cell | 3 studies | 34% ± 8% | |
respiratory goblet cell | 3 studies | 37% ± 21% | |
basal cell | 3 studies | 42% ± 22% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
liver | 100% | 683.56 | 226 / 226 | 92% | 3.69 | 375 / 406 |
kidney | 100% | 685.49 | 89 / 89 | 89% | 3.87 | 798 / 901 |
thymus | 100% | 799.18 | 653 / 653 | 88% | 2.88 | 531 / 605 |
lung | 99% | 583.45 | 574 / 578 | 76% | 3.35 | 883 / 1155 |
brain | 82% | 307.66 | 2168 / 2642 | 92% | 3.60 | 647 / 705 |
pancreas | 100% | 392.89 | 327 / 328 | 71% | 1.70 | 127 / 178 |
ovary | 100% | 872.31 | 180 / 180 | 68% | 2.02 | 293 / 430 |
adrenal gland | 100% | 682.97 | 258 / 258 | 67% | 1.99 | 155 / 230 |
breast | 100% | 646.73 | 459 / 459 | 49% | 2.02 | 546 / 1118 |
stomach | 100% | 366.20 | 359 / 359 | 48% | 1.23 | 138 / 286 |
uterus | 96% | 455.22 | 164 / 170 | 50% | 1.87 | 229 / 459 |
intestine | 95% | 257.17 | 922 / 966 | 45% | 1.23 | 235 / 527 |
skin | 75% | 806.05 | 1354 / 1809 | 63% | 2.83 | 295 / 472 |
prostate | 100% | 362.62 | 244 / 245 | 29% | 0.47 | 145 / 502 |
bladder | 90% | 225.29 | 19 / 21 | 37% | 1.42 | 187 / 504 |
esophagus | 70% | 251.26 | 1018 / 1445 | 44% | 1.57 | 80 / 183 |
eye | 0% | 0 | 0 / 0 | 100% | 10.78 | 80 / 80 |
spleen | 100% | 438.40 | 241 / 241 | 0% | 0 | 0 / 0 |
adipose | 100% | 454.82 | 1201 / 1204 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 73% | 3.78 | 33 / 45 |
blood vessel | 61% | 161.45 | 808 / 1335 | 0% | 0 | 0 / 0 |
heart | 60% | 320.71 | 514 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 45% | 1.07 | 13 / 29 |
peripheral blood | 30% | 111.11 | 277 / 929 | 0% | 0 | 0 / 0 |
muscle | 14% | 20.41 | 115 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0006325 | Biological process | chromatin organization |
GO_0045892 | Biological process | negative regulation of DNA-templated transcription |
GO_0005634 | Cellular component | nucleus |
GO_0005515 | Molecular function | protein binding |
GO_0008270 | Molecular function | zinc ion binding |
GO_0042393 | Molecular function | histone binding |
GO_0003682 | Molecular function | chromatin binding |
Gene name | L3MBTL4 |
Protein name | L3MBTL histone methyl-lysine binding protein 4 Lethal(3)malignant brain tumor-like protein 4 (H-l(3)mbt-like protein 4) (L(3)mbt-like protein 4) (L3mbt-like 4) |
Synonyms | |
Description | FUNCTION: Putative Polycomb group (PcG) protein. PcG proteins maintain the transcriptionally repressive state of genes, probably via a modification of chromatin, rendering it heritably changed in its expressibility (By similarity). . |
Accessions | ENST00000583809.5 ENST00000581231.5 ENST00000400104.7 [Q8NA19-2] ENST00000400105.6 [Q8NA19-1] F8W9S8 ENST00000317931.12 Q8NA19 ENST00000583054.5 J3KRN7 J3KS41 J3QLK8 |